Page last updated: 2024-08-23

colforsin and Lung Injury, Acute

colforsin has been researched along with Lung Injury, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YH; Liu, J; Ma, L; Qiang, D; Qing, C; Xu, Y; Yang, W; Zhang, M; Zhang, Y; Zhen, C1
Hattori, Y; Oishi, H; Takano, K; Takebe, M; Tomita, K; Yamazaki, M; Yokoo, H1

Other Studies

2 other study(ies) available for colforsin and Lung Injury, Acute

ArticleYear
Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models.
    International immunopharmacology, 2011, Volume: 11, Issue:6

    Topics: Acute Lung Injury; Animals; Cell Adhesion; Cells, Cultured; Coleus; Colforsin; Cytokines; Disease Models, Animal; Enzyme Activation; Humans; Inflammation Mediators; Leukocytes, Mononuclear; Lipopolysaccharides; Lung; Mice; Neutrophils; Peroxidase; Rats

2011
Olprinone and colforsin daropate alleviate septic lung inflammation and apoptosis through CREB-independent activation of the Akt pathway.
    American journal of physiology. Lung cellular and molecular physiology, 2012, Volume: 303, Issue:2

    Topics: Acute Lung Injury; Androstadienes; Animals; Apoptosis; Cecum; Colforsin; Cyclic AMP Response Element-Binding Protein; Cytokines; Enzyme Activation; Enzyme Activators; Hypotension; Imidazoles; Ligation; Lung; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Pneumonia; Proto-Oncogene Proteins c-akt; Pyridones; Shock, Septic; Signal Transduction; Wortmannin

2012